MedTrace Logo

Comparison of the Two Immunosuppressive Regimens Based on Tacrolimus and Cyclosporine Following Kidney Transplantation

NCT00204191 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2007-10-19

No results posted yet for this study

Summary

The purpose of this study is to evaluate and compare, in the single center setting, the safety, efficacy and cost-effectiveness of the two standard immunosuppressive regimens based on tacrolimus and cyclosporine.

Conditions

  • Kidney Transplantation

Interventions

DRUG

tacrolimus

Sponsors & Collaborators

  • Astellas Pharma Inc

    collaborator INDUSTRY

  • Uniwersytet Mikolaja Kopernika w Toruniu

    lead OTHER

Principal Investigators

  • Zbigniew Wlodarczyk, MD, PhD · Klinika Transplantologii, Collegium Medicum UMK Torun

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-05-31
Completion
2007-12-31

Countries

  • Poland

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00204191 on ClinicalTrials.gov